全球酵素免疫分析法（ELISA）检测市场规模、份额、趋势和成长分析报告（2026-2034年）

预计酵素免疫分析法(ELISA) 检测市场将从 2025 年的 35.9 亿美元成长到 2034 年的 78.1 亿美元，2026 年至 2034 年的复合年增长率为 9.02%。

由于酵素免疫分析法（ELISA）在疾病诊断和生物医学研究中的广泛应用，全球ELISA市场正经历强劲成长。 ELISA是一种用于检测生物检体中抗体、抗原和蛋白质的实验室技术。它常用于感染疾病、自体免疫疾病和癌症生物标记的诊断。

推动市场发展的主要因素之一是对准确可靠的诊断测试日益增长的需求。医疗机构和实验室高度依赖酵素连结免疫吸附试验（ELISA），因为其具有高灵敏度和特异性。此外，生物技术研发投入的增加以及先进诊断技术的开发也促进了市场成长。

随着全球对快速高效诊断解决方案的需求不断增长，ELISA检测市场预计将持续成长。检查室自动化和多重检测技术的进步有望提高检测效率。在全球医疗体係日益重视疾病早期检测和个人化医疗的背景下，ELISA检测将继续在诊断和研究中发挥关键作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球酵素免疫分析法试验 (ELISA) 市场：依试验类型划分

• 市场分析、洞察与预测
• 夹心ELISA
• 间接ELISA
• 多用途和可携式乙二醇
• 竞争性ELISA

第五章 全球酵素免疫分析法试验 (ELISA) 市场：依应用划分

• 市场分析、洞察与预测
• 免疫学
• 发炎
• 感染疾病
• 癌症
• 蛋白质定量
• 其他的

第六章 全球酵素免疫分析法试验 (ELISA) 市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific. Inc
  • American Laboratory Products Company（ALPCO）
  • BD Biosciences
  • Bio-Rad Laboratories Inc
  • BioMerieux
  • Ortho-Clinical Diagnostics Inc
  • R & D Systems Inc
  • ZEUS Scientific Inc
  • Enzo Life Sciences, Inc
  • Biolegand, Inc

The Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market size is expected to reach USD 7.81 Billion in 2034 from USD 3.59 Billion (2025) growing at a CAGR of 9.02% during 2026-2034.

The global enzyme-linked immunosorbent assay (ELISA) testing market is experiencing strong growth due to its widespread use in disease diagnosis and biomedical research. ELISA is a laboratory technique used to detect antibodies, antigens, and proteins in biological samples. It is commonly used in the diagnosis of infectious diseases, autoimmune disorders, and cancer biomarkers.

One of the major drivers of the market is the increasing demand for accurate and reliable diagnostic testing. Healthcare providers and research laboratories rely heavily on ELISA tests because they offer high sensitivity and specificity. Additionally, rising investments in biotechnology research and the development of advanced diagnostic technologies are boosting the market.

In the future, the ELISA testing market is expected to grow as demand for rapid and efficient diagnostic solutions increases worldwide. Advances in laboratory automation and multiplex testing technologies are likely to enhance testing efficiency. As global healthcare systems emphasize early disease detection and personalized medicine, ELISA testing will continue to play a crucial role in diagnostics and research.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test type

• Sandwich ELISA
• Indirect ELISA
• Multiple and Portable ELISA
• Competitive ELISA

By Applications

• Immunology
• Inflammation
• Infectious Diseases
• Cancer
• Protein Quantification
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, American Laboratory Products Company ALPCO, BD Biosciences, BioRad Laboratories Inc, BioMrieux, OrthoClinical Diagnostics Inc, R D Systems Inc, ZEUS Scientific Inc, Enzo Life Sciences, Inc, Biolegand, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Sandwich ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Indirect ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Multiple and Portable ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Competitive ELISA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY APPLICATIONS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Applications
• 5.2. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Inflammation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Protein Quantification Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Test Type
  • 6.2.2 By Applications
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Test Type
  • 6.3.2 By Applications
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Test Type
  • 6.4.2 By Applications
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Test Type
  • 6.5.2 By Applications
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Test Type
  • 6.6.2 By Applications
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) TESTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Thermo Fisher Scientific. Inc
  • 8.2.2 American Laboratory Products Company (ALPCO)
  • 8.2.3 BD Biosciences
  • 8.2.4 Bio-Rad Laboratories Inc
  • 8.2.5 BioMerieux
  • 8.2.6 Ortho-Clinical Diagnostics Inc
  • 8.2.7 R & D Systems Inc
  • 8.2.8 ZEUS Scientific Inc
  • 8.2.9 Enzo Life Sciences, Inc
  • 8.2.10 Biolegand, Inc